NHL Study
Phase 1 study to evaluate the safety and preliminary efficacy of ATA3219 in subjects with relapsed/refractory B-cell non-Hodgkin’s lymphoma
SLE Study
Phase 1 study to evaluate the safety and preliminary efficacy of ATA3219 in subjects with systemic lupus erythematosus